Dr. Khor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Cleveland, OH 44195
Education & Training
- Cleveland Clinic FoundationFellowship, Cytopathology, 2012 - 2013
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Pathology-Anatomic and Clinical, 2009 - 2012
- Drexel University College of Medicine/Hahnemann UniversityInternship, Transitional Year, 2008 - 2009
- Royal College of Surgeons IrelandClass of 1998
Certifications & Licensure
- OH State Medical License 2009 - 2026
- PA State Medical License 2008 - 2009
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Cytopathology
Publications & Presentations
PubMed
- 22 citationsThe Importance of Protein Kinase A in Prostate Cancer: Relationship to Patient Outcome in Radiation Therapy Oncology Group Trial 92-02Alan Pollack, Kyounghwa Bae, Li Yan Khor, Tahseen Al-Saleem, M. Elizabeth H. Hammond
Clinical Cancer Research. 2009-09-01 - 84 citationsCOX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial.Li Yan Khor, Kyounghwa Bae, Alan Pollack, M. Elizabeth H. Hammond, David J. Grignon
The Lancet. Oncology. 2007-10-01 - 8 citationsProspective Validation of Diagnostic Tumor Biomarkers in Men Treated With Radiotherapy for Prostate Cancer.Alan Pollack, Deukwoo Kwon, Gail Walker, Li Yan Khor, Eric M. Horwitz
Journal of the National Cancer Institute. 2017-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: